David Gillen

David qualified in Medicine, Physiology and Clinical Pharmacology from St. Mary’s Hospital in 1992 and joined Pfizer in 1999, where he spent 12 years in a number of local and global roles, including UK Medical Director and VP of Medical Affairs for Pfizer’s Primary Care Business Unit.

Subsequently David worked in a number of senior roles at Celgene, Gilead Sciences, Vertex Therapeutics and Menarini, working across Specialist Care and Rare Diseases, before joining Norgine in 2022.